Cargando…
Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial
BACKGROUND: The objective of this report is to describe the methods used to develop and validate a computerized system to analyze Humphrey visual fields obtained from patients with non-arteritic anterior ischemic optic neuropathy (NAION) and enrolled in the Ischemic Optic Neuropathy Decompression Tr...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1685661/ https://www.ncbi.nlm.nih.gov/pubmed/17116264 http://dx.doi.org/10.1186/1471-2415-6-34 |
_version_ | 1782131179387879424 |
---|---|
author | Feldon, Steven E Levin, Lori Scherer, Roberta W Arnold, Anthony Chung, Sophia M Johnson, Lenworth N Kosmorsky, Gregory Newman, Steven A Katz, Joanne Langenberg, Patricia Wilson, P David Kelman, Shalom E Dickersin, Kay |
author_facet | Feldon, Steven E Levin, Lori Scherer, Roberta W Arnold, Anthony Chung, Sophia M Johnson, Lenworth N Kosmorsky, Gregory Newman, Steven A Katz, Joanne Langenberg, Patricia Wilson, P David Kelman, Shalom E Dickersin, Kay |
author_sort | Feldon, Steven E |
collection | PubMed |
description | BACKGROUND: The objective of this report is to describe the methods used to develop and validate a computerized system to analyze Humphrey visual fields obtained from patients with non-arteritic anterior ischemic optic neuropathy (NAION) and enrolled in the Ischemic Optic Neuropathy Decompression Trial (IONDT). The IONDT was a multicenter study that included randomized and non-randomized patients with newly diagnosed NAION in the study eye. At baseline, randomized eyes had visual acuity of 20/64 or worse and non-randomized eyes had visual acuity of better than 20/64 or were associated with patients refusing randomization. Visual fields were measured before treatment using the Humphrey Field Analyzer with the 24-2 program, foveal threshold, and size III stimulus. METHODS: We used visual fields from 189 non-IONDT eyes with NAION to develop the computerized classification system. Six neuro-ophthalmologists ("expert panel") described definitions for visual field patterns defects using 19 visual fields representing a range of pattern defect types. The expert panel then used 120 visual fields, classified using these definitions, to refine the rules, generating revised definitions for 13 visual field pattern defects and 3 levels of severity. These definitions were incorporated into a rule-based computerized classification system run on Excel(® )software. The computerized classification system was used to categorize visual field defects for an additional 95 NAION visual fields, and the expert panel was asked to independently classify the new fields and subsequently whether they agreed with the computer classification. To account for test variability over time, we derived an adjustment factor from the pooled short term fluctuation. We examined change in defects with and without adjustment in visual fields of study participants who demonstrated a visual acuity decrease within 30 days of NAION onset (progressive NAION). RESULTS: Despite an agreed upon set of rules, there was not good agreement among the expert panel when their independent visual classifications were compared. A majority did concur with the computer classification for 91 of 95 visual fields. Remaining classification discrepancies could not be resolved without modifying existing definitions. Without using the adjustment factor, visual fields of 63.6% (14/22) patients with progressive NAION and no central defect, and all (7/7) patients with a paracentral defect, worsened within 30 days of NAION onset. After applying the adjustment factor, the visual fields of the same patients with no initial central defect and 5/7 of the patients with a paracentral defect were seen to worsen. CONCLUSION: The IONDT developed a rule-based computerized system that consistently defines pattern and severity of visual fields of NAION patients for use in a research setting. |
format | Text |
id | pubmed-1685661 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-16856612006-12-11 Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial Feldon, Steven E Levin, Lori Scherer, Roberta W Arnold, Anthony Chung, Sophia M Johnson, Lenworth N Kosmorsky, Gregory Newman, Steven A Katz, Joanne Langenberg, Patricia Wilson, P David Kelman, Shalom E Dickersin, Kay BMC Ophthalmol Research Article BACKGROUND: The objective of this report is to describe the methods used to develop and validate a computerized system to analyze Humphrey visual fields obtained from patients with non-arteritic anterior ischemic optic neuropathy (NAION) and enrolled in the Ischemic Optic Neuropathy Decompression Trial (IONDT). The IONDT was a multicenter study that included randomized and non-randomized patients with newly diagnosed NAION in the study eye. At baseline, randomized eyes had visual acuity of 20/64 or worse and non-randomized eyes had visual acuity of better than 20/64 or were associated with patients refusing randomization. Visual fields were measured before treatment using the Humphrey Field Analyzer with the 24-2 program, foveal threshold, and size III stimulus. METHODS: We used visual fields from 189 non-IONDT eyes with NAION to develop the computerized classification system. Six neuro-ophthalmologists ("expert panel") described definitions for visual field patterns defects using 19 visual fields representing a range of pattern defect types. The expert panel then used 120 visual fields, classified using these definitions, to refine the rules, generating revised definitions for 13 visual field pattern defects and 3 levels of severity. These definitions were incorporated into a rule-based computerized classification system run on Excel(® )software. The computerized classification system was used to categorize visual field defects for an additional 95 NAION visual fields, and the expert panel was asked to independently classify the new fields and subsequently whether they agreed with the computer classification. To account for test variability over time, we derived an adjustment factor from the pooled short term fluctuation. We examined change in defects with and without adjustment in visual fields of study participants who demonstrated a visual acuity decrease within 30 days of NAION onset (progressive NAION). RESULTS: Despite an agreed upon set of rules, there was not good agreement among the expert panel when their independent visual classifications were compared. A majority did concur with the computer classification for 91 of 95 visual fields. Remaining classification discrepancies could not be resolved without modifying existing definitions. Without using the adjustment factor, visual fields of 63.6% (14/22) patients with progressive NAION and no central defect, and all (7/7) patients with a paracentral defect, worsened within 30 days of NAION onset. After applying the adjustment factor, the visual fields of the same patients with no initial central defect and 5/7 of the patients with a paracentral defect were seen to worsen. CONCLUSION: The IONDT developed a rule-based computerized system that consistently defines pattern and severity of visual fields of NAION patients for use in a research setting. BioMed Central 2006-11-20 /pmc/articles/PMC1685661/ /pubmed/17116264 http://dx.doi.org/10.1186/1471-2415-6-34 Text en Copyright © 2006 Feldon et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Feldon, Steven E Levin, Lori Scherer, Roberta W Arnold, Anthony Chung, Sophia M Johnson, Lenworth N Kosmorsky, Gregory Newman, Steven A Katz, Joanne Langenberg, Patricia Wilson, P David Kelman, Shalom E Dickersin, Kay Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial |
title | Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial |
title_full | Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial |
title_fullStr | Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial |
title_full_unstemmed | Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial |
title_short | Development and validation of a computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial |
title_sort | development and validation of a computerized expert system for evaluation of automated visual fields from the ischemic optic neuropathy decompression trial |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1685661/ https://www.ncbi.nlm.nih.gov/pubmed/17116264 http://dx.doi.org/10.1186/1471-2415-6-34 |
work_keys_str_mv | AT feldonstevene developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial AT levinlori developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial AT schererrobertaw developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial AT arnoldanthony developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial AT chungsophiam developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial AT johnsonlenworthn developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial AT kosmorskygregory developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial AT newmanstevena developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial AT katzjoanne developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial AT langenbergpatricia developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial AT wilsonpdavid developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial AT kelmanshalome developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial AT dickersinkay developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial AT developmentandvalidationofacomputerizedexpertsystemforevaluationofautomatedvisualfieldsfromtheischemicopticneuropathydecompressiontrial |